Gavriel Fialkoff
Papers
2
Total Citations
16
H-Index
2
About
Gavriel Fialkoff is a researcher focused on advancing viral detection and genomic surveillance, with key contributions to the development of scalable, extraction-free diagnostic protocols for SARS-CoV-2. His work addresses critical bottlenecks in pandemic response—specifically, the need for high-throughput, cost-effective testing that simultaneously identifies infections and tracks viral evolution. Fialkoff’s most cited paper, “Early sample tagging and pooling enables simultaneous SARS-CoV-2 detection and variant sequencing” (2021, 11 citations), introduces a method that bypasses traditional RNA extraction, using early sample tagging and pooling to perform both RT-qPCR detection and variant sequencing in a single workflow. This innovation dramatically reduces reagent use and turnaround time while preserving sensitivity. His earlier work, “ApharSeq: An Extraction-free Early-Pooling Protocol for Massively Multiplexed SARS-CoV-2 Detection” (2020, 5 citations), laid the groundwork for this approach, demonstrating how massively multiplexed testing could be achieved without compromising accuracy. Together, these contributions have informed public health strategies for resource-limited settings and large-scale surveillance, showcasing Fialkoff’s impact on making molecular diagnostics more accessible and informative during a global health crisis.
Research Focus
Key Achievements
Top Papers
- 1
- 2